Ukrainian skeleton racer Vladyslav Heraskevych received a $200,000 gift to support his career following his disqualification from the Olympics.

Nikola Topic, a prominent figure, has shared details about his ongoing chemotherapy treatment for testicular cancer.

The FDA has granted Breakthrough Therapy Designation to Johnson & Johnson's cancer drug, JNJ-73841937, for the treatment of advanced head and neck cancer.

The UAE has initiated two gene therapy projects aimed at addressing the root causes of autism and rare brain disorders in children, marking a significant advancement in treatment approaches.

Piper Sandler has reduced its price target for Akebia Therapeutics (AKBA) to $4, updating its estimates after the company's year-end reports.

An analysis suggests that Viking Therapeutics stock could reach $125, indicating a positive outlook for investors.

Amicus Therapeutics announced its non-GAAP earnings per share of $0.31 and reported revenues of $634 million.

Oscar nominee Óliver Laxe talks about his film 'Sirat,' its international resonance, and the 'shock therapy' of its storyline, stating that 'You Die Watching [It]'.

Candel Therapeutics has priced a public offering aiming to raise $100 million.

Jefferies assigns a high probability of best-in-class efficacy for Definium Therapeutics' DT120, while Evercore notes Tremfya's market share gains for AbbVie but limited future earnings growth. Cognex's CFO sees improving demand, and analysts are bullish on AppLovin, Dave Inc., Chewy, and GoDaddy, despite Super Group facing a 'super simple short thesis'.

An analyst expresses a bullish sentiment on Beam Therapeutics (BEAM) due to the promising trajectory of its drug programs.

Researchers have developed a new blood test that can predict when an individual is likely to start showing Alzheimer’s symptoms, which could aid in developing therapies to prevent or slow the onset of dementia.

Shares of Japan's Sumitomo Pharma fell over 12% due to profit-taking, even after a specialist panel endorsed its iPS cell-based therapy for Parkinson's.

Halozyme Therapeutics, Inc. has released a summary of its fourth-quarter 2025 earnings call, detailing its financial performance.

Ming-Na Wen, Jennifer Beals, and Hubert Smielecki have been cast as Greek gods Hera, Demeter, and Apollo, respectively, in the third season of 'Percy Jackson and the Olympians'.

Corcept Therapeutics' stock declined after an appeals court ruled in favor of Teva Pharmaceuticals in a patent dispute concerning Corcept's drug Korlym.

Analysts are providing their outlook on where Janux Therapeutics (JANX) is headed, offering insights into its future performance.

Rose Byrne delivers a powerful performance as a therapist on the brink of a breakdown due to parenting stress in the new horror-comedy 'If I Had Legs I’d Kick You'.

Structure Therapeutics (GPCR) saw positive developments following the release of favorable clinical trial data.

Paulo Dybala will not undergo surgery despite earlier reports, opting instead for regular therapy to address his injury.

Structure Therapeutics stock has surged 187% in one year, even as one fund reduced its stake by $8 million.

The African Ambassadors Group in Seoul met with the CEO of Herald Media Group to discuss ways to strengthen cooperation between Africa and South Korea.

A witness recounts the final moments before a family of five was killed in a house in Cherating Damai, Malaysia’s Pahang state.

Olympic athlete Allyson Felix highlights the challenges of recovery as a mother compared to an athlete, partnering with Theraflu to advocate for paid sick leave to support parents.

An analysis explores whether CRISPR Therapeutics shares are a good investment opportunity for February.

The boss of Shakhtar Donetsk paid Ukrainian skeleton racer Vladyslav Heraskevych $200,000 after his disqualification from the Games.

An individual expresses their desire to become a licensed therapist, driven by a passion for helping others.

WWE's Bianca Belair has shared videos of her first day of physical therapy, just one day after undergoing surgery on her knuckle.

Helus announced positive peer-reviewed data for its psychedelic therapy, indicating potential advancements in mental health treatment.

NeuroOne aims for at least $10.5 million in revenue in 2026 as it continues to develop its brain and pain therapy platforms.

OptiBiotix shares experienced a rise after the company announced its decision not to sell its stake in SkinBioTherapeutics.

Halozyme Therapeutics is preparing to announce its Q4 2025 earnings, drawing attention from investors keen on its financial performance and projections.

A Ukrainian athlete was barred from the Winter Olympics after insisting on wearing a helmet featuring photos of athletes, sparking debate about the International Olympic Committee's rules.

Multiple biotech and pharmaceutical companies, including Legend Biotech, Corcept Therapeutics, and Ultragenyx, have released updates on their drug pipelines, clinical trial data, and regulatory interactions, impacting market outlook.

A consortium led by U.S. energy giant Chevron has signed exclusive lease agreements to explore for natural gas in waters off southern Greece.

The US military has boarded an oil tanker in the Indian Ocean, having tracked its movements all the way from the Caribbean. This action marks another instance of US intervention concerning maritime oil shipments.

A director at Protagonist Therapeutics has sold 20,000 shares of the company's stock, occurring during a period of strong performance for the company's shares.

In Nigeria, where access to qualified therapists is limited and costly, many individuals are turning to AI chatbots for advice and therapy. This trend highlights AI's role in filling mental healthcare gaps, while also prompting calls for tighter regulation.

Canada concluded a perfect preliminary campaign in Olympic ice hockey, while Team GB celebrated a 'Super Sunday' with multiple gold medals, amidst escalating curling controversy involving Britain.

The 23rd San Francisco Greek Film Festival is scheduled to run from March 14-21, with a special screening on February 20.

A migrant boat sank off the coast of Crete, resulting in five fatalities, 26 individuals missing, and 20 people rescued.

The Hellenic Aesthetic organization is scheduled to host a Marti Party bracelet making event this month.

Travere Therapeutics' Q4 earnings call provided an overview of the company's financial results and pipeline developments.

A drug developed by Ocular Therapeutix for an eye disorder has shown promise in clinical trials, but the results did not meet investor expectations.

An earnings preview for Summit Therapeutics' fourth quarter of 2025 has been published.

PTC Therapeutics has outlined a target of 19%-36% product revenue growth by 2026, driven by accelerating global momentum for its Sephience product.

An article highlights the significant advancements in gene therapy and suggests potential investment opportunities in this rapidly evolving field.

Roche has received FDA review for a new breast cancer therapy, marking a significant step in developing advanced treatments for the disease.

Analysts are bullish on several biotech companies, including GH Research, Cybin D/B/A Helus Pharma, and COMPASS Pathways, following a psychedelics symposium and positive model updates, with Baird lowering Bright Minds Biosciences' price target but maintaining an Outperform rating.

Analysts are optimistic about Vera Therapeutics (VERA) following the appointment of a new commercial chief.

The NHS is piloting a program that turns patients into stand-up comedians, exploring laughter as a therapeutic intervention.

Travere Therapeutics has outlined its growth strategy driven by FILSPARI and a new milestone in FSGS research for 2026.

Indian troops successfully foiled an infiltration attempt along the Line of Control in Jammu's Sunderbani sector and busted a terror module in a separate operation in Nowshera.

Herantis Pharma has been selected to receive a Horizon 2025 Grant, supporting its research and development efforts.

Led by President Donald Trump, the 'Board of Peace' held its inaugural meeting to discuss the reconstruction efforts in Gaza.

Fiscal discipline and structural reforms are yielding positive results, leading to a resurgence in Europe's peripheral economies.

Terrax, Galactus' formidable herald, makes an appearance in the latest LEGO Marvel Avengers: Strange Tails, showcasing his imposing design and immense power.

Johnson & Johnson plans to construct a new $1 billion cell and gene therapy manufacturing facility in Pennsylvania, expanding its production capabilities.

Perspective Therapeutics, Inc. (CATX) is gaining momentum with new funding and progress in its clinical trials, indicating positive developments for the company.

Kymera Therapeutics and Cogent Biosciences stocks have seen substantial gains over the past year, attracting significant investor interest, though some funds have trimmed their stakes.

Sarah McLachlan, 58, reveals that therapy helped her mend her relationship with her older daughter, requiring her to 'eat a lot of humble pie.'

Travere Therapeutics is scheduled to report its Q4 2025 earnings, with the market awaiting its latest financial disclosures.

The Municipality of Nea Irakleio has received ten centuries-old olive trees through a transplantation program run by OSE, which will be integrated into the local area.

After being disqualified from the Milan Cortina Olympics, Ukrainian skeleton racer Vladyslav Heraskevych returned to Kyiv, now planning a fundraiser for fallen athletes amidst his capital's struggles.

Jacob Funds has established positions in Cabaletta Bio (CABA) and Prime Medicine (PRME), focusing on next-generation gene therapy companies.

Halozyme Therapeutics reported a non-GAAP EPS of -$0.24, missing estimates, but its revenue of $451M surpassed expectations.

Bristol Myers has received FDA priority review for its multiple myeloma therapy, indicating a potential acceleration in the drug's approval process.

Frankie del Duca and Josh Williamson of Team USA are competing in the 2-man bobsled final at the Olympics, with live results and highlights being tracked.

Outlook Therapeutics has announced a net loss for its first quarter, as reported by TradingView.

Several financial institutions have updated their price targets for a range of companies, including CytomX Therapeutics, Upwork, Coursera, Tripadvisor, and The Wendy's Company, while maintaining various ratings.

H.C. Wainwright has reiterated its 'Buy' rating on Beam Therapeutics (BEAM) following the FDA's expedited approval of BEAM-302.

Reviews cover Delaine Le Bas's exhibition exploring connection and exclusion, and Mico Montes's horror portmanteau 'Bare Skin' which relies on atmosphere and trauma stories.

An article offers guidance on identifying and investing in high-growth stocks, particularly for investors with a limited budget.

A New Jersey man has been found guilty of killing members of the Greek-American Karydis-Caneiro family, concluding a high-profile murder trial.

A review of Mico Montes's debut horror feature 'Bare Skin' describes it as a perplexing portmanteau that relies heavily on atmosphere and trauma stories.

Several financial firms, including Wedbush, Needham, Evercore ISI, and TD Cowen, have updated their price targets for a range of companies, reflecting revised market outlooks and company performance expectations.

Great Britain celebrates a golden day with multiple medals, while Italy's Federica Brignone secures her second gold. Dutch skater Femke Kok dominates the 500m speed skating, and skier Lindsey Vonn prepares for surgery after a crash.

While peptide therapy gains popularity as an anti-aging solution, health experts warn that the hype may outpace scientific evidence and raise significant safety concerns.

An article analyzes the future prospects of CRISPR Therapeutics stock, questioning whether its current valuation is sustainable or if its potential will be realized.

On this day in 1980, an unheralded American team achieved one of the greatest upsets in sports history, defeating the formidable Soviet Union ice hockey team in what became known as the 'Miracle on Ice'.

The National Herald discusses how India's 'brain gain' phenomenon, where skilled professionals return to the country, is not translating into anticipated advantages.

PTC Therapeutics' fourth-quarter earnings call highlights have been released, providing key insights into the company's financial performance.

Candel Therapeutics has entered into a $100 million funding agreement with RTW Investments and simultaneously launched a $100 million public offering.

Buckeye Trail's Josey Rome overcame years of physical therapy and surgeries to forge her own successful path on the basketball court.

Analysts express strong confidence in C4 Therapeutics' Cemsidomide, projecting a significant 270% upside potential for the company.

This article provides a preview of Axsome Therapeutics' financial performance ahead of its fourth-quarter 2025 earnings report.

The Taliban is increasing its enforcement of rules regarding women's dress in the city of Herat, with crackdowns observed in hospitals, seminaries, and on buses.

AbbVie has received FDA approval for its Venclexta-acalabrutinib combination therapy as a first-line treatment for chronic lymphocytic leukemia (CLL).

TD Cowen maintains a cautious outlook on Amicus Therapeutics (FOLD) even with positive revenue projections for 2025.

Candel Therapeutics has priced a $100 million public offering at $5.45 per share.

Candel Therapeutics has announced a proposed public offering aiming to raise $100 million.

Travere Therapeutics, Inc. (TVTX) is seen as well-positioned for long-term growth within the rare disease market.

Fantasy baseball analyst Scott Pianowski wraps up his Shuffle Up series with the relief pitchers.

Hedge funds are identifying Iovance Biotherapeutics Inc. (IOVA) and AstraZeneca PLC (AZN) as leading immunotherapy stocks to buy.

A neurologist discusses the latest advancements in sleep science, including the potential for training oneself to have more lucid dreams and its therapeutic applications.

Regeneron has been granted FDA priority review for its therapy targeting a rare bone disorder, potentially accelerating its path to market.

Actor Robert Pattinson recalled an incident where his therapist asked if he was on drugs because they 'couldn’t understand him' during a discussion with Zendaya.

Iovance Biotherapeutics Inc. is gaining momentum following the release of new trial data.

A new article explores the scientific reasons why dancing is an effective tool against depression, highlighting its powerful therapeutic benefits.

The African Group of Ambassadors in Seoul, representing 19 African embassies, met with Herald Media Group CEO Choi Jin-young to discuss avenues for Africa-Korea cooperation.

Britain's Matt Weston holds the midpoint lead in the Olympic skeleton event, with Heraskevych out of contention.

Actor Robert Pattinson shared an anecdote about a mental health professional once accusing him of being on drugs during a conversation.

ImmunityBio's stock saw an increase after its bladder cancer therapy received approval in the European Union.

Wellgistics Health has invested in a mental health AI startup as part of its strategy to expand its software offerings.

A Ukrainian skeleton racer, disqualified at the Winter Olympics, was gifted $200,000 by the owner of Shakhtar Donetsk, matching the prize for national gold medallists.

Voting is open for the Gaylord Herald Times Athlete of the Week, covering performances from February 9-14.

New late-stage trial data for a wet AMD therapy using ocular drops has been released, indicating potential advancements in the treatment of this eye condition.

A Russian woman living in Milan carried a Ukraine placard at the Winter Olympics opening ceremony, symbolizing her opposition to Russia's war.

Researchers have found that a single dose of the potent psychedelic drug DMT, when used with psychotherapy, could significantly help treat major depressive disorder.

This cluster includes news on analyst ratings, significant investment filings, regulatory compliance, proposed rights issues, and new business orders for individual companies.

Berlinale Chief Tricia Tuttle discusses the festival's role in championing indie films and its susceptibility to political controversy. Meanwhile, director Kornél Mundruczó and actress Chloe East share insights on their film 'At The Sea,' premiering in competition at the festival.

The Pima County Sheriff defended his officers amid criticism regarding the Nancy Guthrie kidnapping case, as the FBI announced DNA matching a suspect's glove was recovered near the Guthrie home.

Actor Lars Eidinger discusses his initial desire for Isabelle Huppert's vampire role in 'The Blood Countess' and his eventual casting as the vampire's therapist.

Olympic chiefs are facing strong criticism for their decision to ban Ukrainian Olympian Heraskevych, with calls for an apology from athletes who believe the IOC has made a significant error.

The Korea Herald provides information on how residents can access medical facilities and emergency services during the Seollal holiday.